BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35063931)

  • 21. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.
    Zhou C; Wu F; Chai P; Shi Y; Ye J; Shi X; Tan J; Ding Y; Luo Y; Esmaeli B; Jia R; Fan X
    J Am Acad Dermatol; 2019 Jun; 80(6):1608-1617.e1. PubMed ID: 30639290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Metastatic Eyelid Carcinoma.
    Bonavolontà P; Dell'Aversana Orabona G; Abbate V; Iaconetta G; Bonavolontà G; Califano L
    J Craniofac Surg; 2017 Nov; 28(8):e722-e725. PubMed ID: 28885435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.
    Kaliki S; Gupta A; Ali MH; Ayyar A; Naik MN
    Int Ophthalmol; 2016 Oct; 36(5):681-90. PubMed ID: 26830096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
    Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
    Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher Ki67 Index, Nodal Involvement, and Invasive Growth Were High Risk Factors for Worse Prognosis in Conventional Mammary Analogue Secretory Carcinoma.
    Sun J; Wang L; Tian Z; Hu Y; Xia R; Li J
    J Oral Maxillofac Surg; 2019 Jun; 77(6):1187-1202. PubMed ID: 30779892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma.
    Sa HS; Rubin ML; Ning J; Li W; Tetzlaff MT; McGovern SL; Paulino AC; Herzog CE; Gill JB; Esmaeli B
    JAMA Ophthalmol; 2020 Apr; 138(4):374-381. PubMed ID: 32105303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmed death receptor Ligand 1 expression in eyelid sebaceous carcinoma: a consecutive case series of 41 patients.
    Xu S; Yu H; Fu G; Fan X; Jia R
    Acta Ophthalmol; 2019 May; 97(3):e390-e396. PubMed ID: 29862664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid.
    Husain A; Blumenschein G; Esmaeli B
    Int J Dermatol; 2008 Mar; 47(3):276-9. PubMed ID: 18289332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea.
    Choi YJ; Jin HC; Lee MJ; Kim N; Choung HK; Khwarg SI
    Jpn J Ophthalmol; 2014 Jul; 58(4):327-33. PubMed ID: 24763914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management.
    Lam SC; Li EYM; Yuen HKL
    Br J Ophthalmol; 2018 Dec; 102(12):1723-1727. PubMed ID: 29459429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion.
    Chao AN; Shields CL; Krema H; Shields JA
    Ophthalmology; 2001 Oct; 108(10):1877-83. PubMed ID: 11581065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
    Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
    JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sebaceous carcinoma of the eyelid: 21-year experience in a Nordic country.
    Niinimäki P; Siuko M; Tynninen O; Kivelä TT; Uusitalo M
    Acta Ophthalmol; 2021 Mar; 99(2):181-186. PubMed ID: 32749765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eyelid carcinoma: An experience from a tertiary cancer center.
    Thiagarajan S; Bahani A; Chaukar D; Dcruz AK
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S48-S52. PubMed ID: 33380651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant Systemic Chemotherapy in the Management of Extensive Eyelid Sebaceous Gland Carcinoma: A study of 10 Cases.
    Kaliki S; Ayyar A; Nair AG; Mishra DK; Reddy VA; Naik MN
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):35-9. PubMed ID: 25675161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
    Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
    Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
    Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.
    Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
    Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.
    Kaliki S; Ayyar A; Dave TV; Ali MJ; Mishra DK; Naik MN
    Eye (Lond); 2015 Jul; 29(7):958-63. PubMed ID: 25998946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal cell carcinoma of the eyelids and periorbital region in a Turkish population.
    Soysal HG; Soysal E; Markoç F; Ardiç F
    Ophthalmic Plast Reconstr Surg; 2008; 24(3):201-6. PubMed ID: 18520835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.